TROY T. DESAI
- Type
- Physician · Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Neurology
- Where
- Clairton, PA
- NPI
- 1861727737
- Received
- $173,626 in 178 records, 2019 to 2025
- As principal investigator
- $154,399 of research payments to others in 34 records
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 15 | $5,815 |
| 2024 | General payment | 19 | $7,604 |
| 2023 | General payment | 19 | $17,287 |
| 2022 | General payment | 16 | $21,394 |
| 2021 | General payment | 28 | $30,353 |
| 2020 | General payment | 9 | $11,748 |
| 2019 | General payment | 72 | $79,422 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| Biogen, Inc. | 77 | $84,514 | 2019–2024 |
| Genentech USA, Inc. | 39 | $47,483 | 2019–2024 |
| Novartis Pharmaceuticals Corporation | 26 | $26,891 | 2019–2020 |
| E.R. Squibb & Sons, L.L.C. | 10 | $7,619 | 2021–2025 |
| Teva Pharmaceuticals USA, Inc. | 3 | $5,640 | 2019 |
| TG Therapeutics, Inc. | 6 | $393 | 2023–2025 |
| Celgene Corporation | 1 | $300 | 2024 |
| EMD Serono, Inc. | 4 | $179 | 2025 |
| ABBVIE INC. | 6 | $148 | 2024–2025 |
| GENZYME CORPORATION | 1 | $125 | 2021 |
| Genentech, Inc. | 2 | $124 | 2023–2025 |
| Alexion Pharmaceuticals, Inc. | 1 | $120 | 2019 |
| SANOFI-AVENTIS U.S. LLC | 1 | $71 | 2020 |
| Horizon Therapeutics plc | 1 | $15 | 2023 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 62 | $137,523 |
| Consulting Fee | 13 | $22,788 |
| Travel and Lodging | 17 | $6,882 |
| Food and Beverage | 85 | $5,543 |
| Gift | 1 | $890 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-16 | TG Therapeutics, Inc. | $111 | Food and Beverage | In-kind items and services | BRIUMVI Drug, Immunology | 2025 | |
| 2025-12-16 | EMD Serono, Inc. | $38 | Food and Beverage | Cash or cash equivalent | 2025 | ||
| 2025-12-11 | EMD Serono, Inc. | $81 | Food and Beverage | Cash or cash equivalent | 2025 | ||
| 2025-11-18 | E.R. Squibb & Sons, L.L.C. | $1,760 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2025 | |
| 2025-10-28 | E.R. Squibb & Sons, L.L.C. | $113 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2025 | |
| 2025-10-23 | EMD Serono, Inc. | $9 | Food and Beverage | Cash or cash equivalent | 2025 | ||
| 2025-10-02 | EMD Serono, Inc. | $50 | Food and Beverage | Cash or cash equivalent | 2025 | ||
| 2025-08-12 | ABBVIE INC. | $27 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-06-04 | E.R. Squibb & Sons, L.L.C. | $1,760 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2025 | |
| 2025-05-13 | E.R. Squibb & Sons, L.L.C. | $114 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2025 | |
| 2025-04-11 | E.R. Squibb & Sons, L.L.C. | $220 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-02-24 | TG Therapeutics, Inc. | $95 | Food and Beverage | In-kind items and services | BRIUMVI Drug, Immunology | 2025 | |
| 2025-02-20 | Genentech, Inc. | $40 | Food and Beverage | In-kind items and services | Ocrevus Biological, Immunology | 2025 | |
| 2025-02-20 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | QULIPTA Drug, NEUROSCIENCE | 2025 | |
| 2025-01-07 | E.R. Squibb & Sons, L.L.C. | $1,379 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2025 | |
| 2024-12-20 | ABBVIE INC. | $29 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2024 | |
| 2024-10-25 | E.R. Squibb & Sons, L.L.C. | $1,478 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2024 | |
| 2024-10-17 | E.R. Squibb & Sons, L.L.C. | $591 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2024 | |
| 2024-10-09 | E.R. Squibb & Sons, L.L.C. | $114 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2024 | |
| 2024-10-03 | Genentech USA, Inc. | $100 | Food and Beverage | In-kind items and services | Ocrevus Zunovo Biological, Immunology | 2024 | |
| 2024-10-03 | Genentech USA, Inc. | $18 | Food and Beverage | In-kind items and services | Ocrevus Zunovo Biological, Immunology | 2024 | |
| 2024-09-13 | Biogen, Inc. | $449 | Consulting Fee | Cash or cash equivalent | VUMERITY Drug, Neurology | 2024 | |
| 2024-09-12 | Biogen, Inc. | $1,347 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VUMERITY Drug, Neurology | 2024 | |
| 2024-09-05 | ABBVIE INC. | $29 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2024 | |
| 2024-08-08 | Genentech USA, Inc. | $131 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-07-10 | TG Therapeutics, Inc. | $60 | Food and Beverage | In-kind items and services | BRIUMVI Drug, Immunology | 2024 | |
| 2024-06-27 | Biogen, Inc. | $1,347 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VUMERITY Drug, Neurology | 2024 | |
| 2024-06-13 | ABBVIE INC. | $31 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2024 | |
| 2024-05-07 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | UBRELVY Drug, NEUROSCIENCE | 2024 | |
| 2024-04-25 | Biogen, Inc. | $1,347 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VUMERITY Drug, Neurology | 2024 | |
| 2024-04-10 | Biogen, Inc. | $112 | Consulting Fee | Cash or cash equivalent | 2024 | ||
| 2024-03-13 | TG Therapeutics, Inc. | $52 | Food and Beverage | In-kind items and services | BRIUMVI Drug, Immunology | 2024 | |
| 2024-03-11 | Celgene Corporation | $300 | Consulting Fee | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2024 | |
| 2024-01-18 | TG Therapeutics, Inc. | $50 | Food and Beverage | In-kind items and services | BRIUMVI Drug, Immunology | 2024 | |
| 2023-10-18 | Biogen, Inc. | $1,224 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2023 | ||
| 2023-09-15 | Biogen, Inc. | $1,224 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VUMERITY Drug, Neurology | 2023 | |
| 2023-08-28 | TG Therapeutics, Inc. | $23 | Food and Beverage | In-kind items and services | BRIUMVI Drug, Immunology | 2023 | |
| 2023-07-20 | Genentech, Inc. | $83 | Food and Beverage | In-kind items and services | Ocrevus Biological, Immunology | 2023 | |
| 2023-06-28 | Biogen, Inc. | $3,264 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Tysabri Biological, Neurology | 2023 | |
| 2023-06-28 | Biogen, Inc. | $1,383 | Travel and Lodging | In-kind items and services | Tysabri Biological, Neurology | 2023 | |
| 2023-06-28 | Biogen, Inc. | $30 | Food and Beverage | In-kind items and services | Tysabri Biological, Neurology | 2023 | |
| 2023-06-13 | Biogen, Inc. | $25 | Food and Beverage | In-kind items and services | 2023 | ||
| 2023-05-20 | Genentech USA, Inc. | $218 | Food and Beverage | In-kind items and services | Ocrevus Biological, Immunology | 2023 | |
| 2023-05-19 | Genentech USA, Inc. | $5,650 | Consulting Fee | Cash or cash equivalent | Ocrevus Biological, Immunology | 2023 | |
| 2023-05-19 | Genentech USA, Inc. | $346 | Travel and Lodging | Cash or cash equivalent | Ocrevus Biological, Immunology | 2023 | |
| 2023-05-19 | Genentech USA, Inc. | $312 | Travel and Lodging | Cash or cash equivalent | Ocrevus Biological, Immunology | 2023 | |
| 2023-05-03 | Biogen, Inc. | $8 | Food and Beverage | In-kind items and services | 2023 | ||
| 2023-04-04 | Biogen, Inc. | $102 | Consulting Fee | Cash or cash equivalent | 2023 | ||
| 2023-03-14 | Horizon Therapeutics plc | $15 | Food and Beverage | In-kind items and services | UPLIZNA Drug, UPLIZNA | 2023 | |
| 2023-02-23 | Biogen, Inc. | $9 | Food and Beverage | In-kind items and services | 2023 | ||
| 2023-02-23 | Biogen, Inc. | $9 | Food and Beverage | In-kind items and services | 2023 | ||
| 2023-02-16 | Biogen, Inc. | $3,264 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Tysabri Biological, Neurology | 2023 | |
| 2023-02-16 | Biogen, Inc. | $94 | Food and Beverage | In-kind items and services | Tysabri Biological, Neurology | 2023 | |
| 2022-10-25 | Genentech USA, Inc. | $2,530 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | OCREVUS Biological, Immunology | 2022 | |
| 2022-10-25 | Genentech USA, Inc. | $105 | Food and Beverage | In-kind items and services | OCREVUS Biological, Immunology | 2022 | |
| 2022-07-19 | Biogen, Inc. | $1,938 | Consulting Fee | Cash or cash equivalent | 2022 | ||
| 2022-05-24 | Genentech USA, Inc. | $2,530 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | OCREVUS Biological, Immunology | 2022 | |
| 2022-05-24 | Genentech USA, Inc. | $40 | Food and Beverage | In-kind items and services | OCREVUS Biological, Immunology | 2022 | |
| 2022-04-20 | Genentech USA, Inc. | $2,530 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | OCREVUS Biological, Immunology | 2022 | |
| 2022-04-20 | Genentech USA, Inc. | $109 | Food and Beverage | In-kind items and services | OCREVUS Biological, Immunology | 2022 | |
| 2022-04-14 | Biogen, Inc. | $38 | Food and Beverage | In-kind items and services | VUMERITY Drug, Neurology | 2022 | |
| 2022-04-06 | Biogen, Inc. | $2,856 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | PLEGRIDY Biological, Neurology | 2022 | |
| 2022-04-06 | Biogen, Inc. | $47 | Food and Beverage | In-kind items and services | PLEGRIDY Biological, Neurology | 2022 | |
| 2022-03-23 | Biogen, Inc. | $2,856 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | TYSABRI Biological, Neurology | 2022 | |
| 2022-03-23 | Biogen, Inc. | $40 | Food and Beverage | In-kind items and services | TYSABRI Biological, Neurology | 2022 | |
| 2022-03-09 | Biogen, Inc. | $2,856 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | PLEGRIDY Biological, Neurology | 2022 | |
| 2022-03-09 | Biogen, Inc. | $47 | Food and Beverage | In-kind items and services | PLEGRIDY Biological, Neurology | 2022 | |
| 2022-03-08 | Biogen, Inc. | $2,856 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VUMERITY Drug, Neurology | 2022 | |
| 2022-02-07 | Biogen, Inc. | $12 | Food and Beverage | In-kind items and services | 2022 | ||
| 2021-12-07 | E.R. Squibb & Sons, L.L.C. | $89 | Food and Beverage | Cash or cash equivalent | ZEPOSIA Drug, Neuroscience | 2021 | |
| 2021-11-16 | Biogen, Inc. | $2,688 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | TYSABRI Biological, NEUROLOGY | 2021 | |
| 2021-11-16 | Biogen, Inc. | $52 | Food and Beverage | Cash or cash equivalent | TYSABRI Biological, NEUROLOGY | 2021 | |
| 2021-11-16 | Biogen, Inc. | $49 | Food and Beverage | Cash or cash equivalent | TYSABRI Biological, NEUROLOGY | 2021 | |
| 2021-11-11 | Biogen, Inc. | $82 | Food and Beverage | Cash or cash equivalent | 2021 | ||
| 2021-11-02 | Genentech USA, Inc. | $22 | Food and Beverage | In-kind items and services | OCREVUS Biological, Immunology | 2021 | |
| 2021-10-28 | Biogen, Inc. | $2,688 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | TYSABRI Biological, NEUROLOGY | 2021 | |
| 2021-10-28 | Biogen, Inc. | $76 | Food and Beverage | Cash or cash equivalent | TYSABRI Biological, NEUROLOGY | 2021 | |
| 2021-10-21 | GENZYME CORPORATION | $125 | Food and Beverage | In-kind items and services | 2021 | ||
| 2021-10-20 | Genentech USA, Inc. | $1,520 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | OCREVUS Biological, Immunology | 2021 | |
| 2021-09-30 | Genentech USA, Inc. | $2,530 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | OCREVUS Biological, Immunology | 2021 | |
| 2021-09-30 | Genentech USA, Inc. | $49 | Food and Beverage | In-kind items and services | OCREVUS Biological, Immunology | 2021 | |
| 2021-08-17 | Biogen, Inc. | $3,456 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | TYSABRI Biological, NEUROLOGY | 2021 | |
| 2021-08-17 | Biogen, Inc. | $784 | Travel and Lodging | Cash or cash equivalent | TYSABRI Biological, NEUROLOGY | 2021 | |
| 2021-08-17 | Biogen, Inc. | $21 | Food and Beverage | Cash or cash equivalent | TYSABRI Biological, NEUROLOGY | 2021 | |
| 2021-08-03 | Biogen, Inc. | $11 | Food and Beverage | In-kind items and services | 2021 | ||
| 2021-06-23 | Biogen, Inc. | $2,688 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2021 | ||
| 2021-06-23 | Biogen, Inc. | $84 | Food and Beverage | Cash or cash equivalent | 2021 | ||
| 2021-06-10 | Biogen, Inc. | $384 | Consulting Fee | Cash or cash equivalent | VUMERITY Drug, NEUROLOGY | 2021 | |
| 2021-06-09 | Biogen, Inc. | $82 | Food and Beverage | Cash or cash equivalent | 2021 | ||
| 2021-05-27 | Genentech USA, Inc. | $1,520 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | OCREVUS Biological, Immunology | 2021 | |
| 2021-04-29 | Genentech USA, Inc. | $1,520 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | OCREVUS Biological, Immunology | 2021 | |
| 2021-04-22 | Biogen, Inc. | $2,048 | Consulting Fee | Cash or cash equivalent | TYSABRI Biological, NEUROLOGY | 2021 | |
| 2021-03-18 | Genentech USA, Inc. | $1,520 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | OCREVUS Biological, Immunology | 2021 | |
| 2021-03-02 | Genentech USA, Inc. | $2,435 | Consulting Fee | Cash or cash equivalent | OCREVUS Biological, Immunology | 2021 | |
| 2021-02-23 | Biogen, Inc. | $1,152 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | TYSABRI Biological, NEUROLOGY | 2021 | |
| 2021-02-18 | Biogen, Inc. | $1,152 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | TYSABRI Biological, NEUROLOGY | 2021 | |
| 2021-02-17 | Genentech USA, Inc. | $1,520 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | OCREVUS Biological, Immunology | 2021 | |
| 2020-10-28 | Genentech USA, Inc. | $1,520 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | OCREVUS Biological, Immunology | 2020 | |
| 2020-09-01 | Biogen, Inc. | $1,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2020 | ||
| 2020-08-27 | Biogen, Inc. | $1,440 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | VUMERITY Drug, NEUROLOGY | 2020 | |
| 2020-08-26 | Genentech USA, Inc. | $1,520 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | OCREVUS Biological, Immunology | 2020 | |
| 2020-05-01 | Novartis Pharmaceuticals Corporation | $1,330 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | MAYZENT Drug, NEUROSCIENCE | 2020 | |
| 2020-03-05 | Biogen, Inc. | $2,880 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | TECFIDERA Drug, NEUROLOGY | 2020 | |
| 2020-02-28 | SANOFI-AVENTIS U.S. LLC | $71 | Food and Beverage | In-kind items and services | AUBAGIO Drug, Neurology | 2020 | |
| 2020-02-27 | Genentech USA, Inc. | $107 | Food and Beverage | In-kind items and services | 2020 | ||
| 2020-01-28 | Biogen, Inc. | $1,080 | Consulting Fee | Cash or cash equivalent | 2020 | ||
| 2019-12-19 | Biogen, Inc. | $3,240 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | TECFIDERA Drug, NEUROLOGY | 2019 | |
| 2019-12-19 | Biogen, Inc. | $145 | Travel and Lodging | Cash or cash equivalent | TECFIDERA Drug, NEUROLOGY | 2019 | |
| 2019-12-19 | Biogen, Inc. | $40 | Food and Beverage | Cash or cash equivalent | TECFIDERA Drug, NEUROLOGY | 2019 | |
| 2019-11-07 | Novartis Pharmaceuticals Corporation | $1,330 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | MAYZENT Drug, NEUROSCIENCE | 2019 | |
| 2019-10-24 | Genentech USA, Inc. | $4,040 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | OCREVUS Biological, Immunology | 2019 | |
| 2019-10-24 | Genentech USA, Inc. | $177 | Travel and Lodging | Cash or cash equivalent | OCREVUS Biological, Immunology | 2019 | |
| 2019-10-24 | Genentech USA, Inc. | $54 | Food and Beverage | In-kind items and services | OCREVUS Biological, Immunology | 2019 | |
| 2019-10-15 | Novartis Pharmaceuticals Corporation | $890 | Gift | In-kind items and services | GILENYA Drug, NEUROSCIENCE | 2019 | |
| 2019-10-03 | Novartis Pharmaceuticals Corporation | $1,330 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | MAYZENT Drug, NEUROSCIENCE | 2019 | |
| 2019-09-30 | Novartis Pharmaceuticals Corporation | $1,330 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | MAYZENT Drug, NEUROSCIENCE | 2019 | |
| 2019-09-27 | Teva Pharmaceuticals USA, Inc. | $2,115 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COPAXONE Drug, Central Nervous System | 2019 | |
| 2019-09-26 | Novartis Pharmaceuticals Corporation | $2,660 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | GILENYA Drug, NEUROSCIENCE | 2019 | |
| 2019-09-26 | Novartis Pharmaceuticals Corporation | $122 | Food and Beverage | In-kind items and services | GILENYA Drug, NEUROSCIENCE | 2019 | |
| 2019-09-23 | Novartis Pharmaceuticals Corporation | $2,660 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | MAYZENT Drug, NEUROSCIENCE | 2019 | |
| 2019-09-23 | Novartis Pharmaceuticals Corporation | $120 | Food and Beverage | In-kind items and services | MAYZENT Drug, NEUROSCIENCE | 2019 | |
| 2019-09-12 | Novartis Pharmaceuticals Corporation | $2,660 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | GILENYA Drug, NEUROSCIENCE | 2019 | |
| 2019-09-12 | Novartis Pharmaceuticals Corporation | $88 | Food and Beverage | In-kind items and services | GILENYA Drug, NEUROSCIENCE | 2019 | |
| 2019-08-26 | Biogen, Inc. | $2,520 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | TECFIDERA Drug, NEUROLOGY | 2019 | |
| 2019-08-26 | Biogen, Inc. | $115 | Food and Beverage | Cash or cash equivalent | TECFIDERA Drug, NEUROLOGY | 2019 | |
| 2019-08-13 | Alexion Pharmaceuticals, Inc. | $120 | Food and Beverage | In-kind items and services | SOLIRIS Drug, Immunology | 2019 | |
| 2019-08-12 | Biogen, Inc. | $2,520 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | TECFIDERA Drug, NEUROLOGY | 2019 | |
| 2019-08-12 | Biogen, Inc. | $46 | Food and Beverage | Cash or cash equivalent | TECFIDERA Drug, NEUROLOGY | 2019 | |
| 2019-08-07 | Novartis Pharmaceuticals Corporation | $2,660 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | MAYZENT Drug, NEUROSCIENCE | 2019 | |
| 2019-08-07 | Novartis Pharmaceuticals Corporation | $696 | Travel and Lodging | Cash or cash equivalent | MAYZENT Drug, NEUROSCIENCE | 2019 | |
| 2019-08-07 | Novartis Pharmaceuticals Corporation | $33 | Food and Beverage | In-kind items and services | MAYZENT Drug, NEUROSCIENCE | 2019 | |
| 2019-07-31 | Novartis Pharmaceuticals Corporation | $1,330 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | MAYZENT Drug, NEUROSCIENCE | 2019 | |
| 2019-07-31 | Novartis Pharmaceuticals Corporation | $17 | Food and Beverage | In-kind items and services | MAYZENT Drug, NEUROSCIENCE | 2019 | |
| 2019-07-30 | Novartis Pharmaceuticals Corporation | $2,660 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | MAYZENT Drug, NEUROSCIENCE | 2019 | |
| 2019-07-30 | Novartis Pharmaceuticals Corporation | $122 | Food and Beverage | In-kind items and services | MAYZENT Drug, NEUROSCIENCE | 2019 | |
| 2019-07-25 | Genentech USA, Inc. | $4,040 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | OCREVUS Biological, Immunology | 2019 | |
| 2019-07-25 | Genentech USA, Inc. | $190 | Travel and Lodging | Cash or cash equivalent | OCREVUS Biological, Immunology | 2019 | |
| 2019-07-25 | Genentech USA, Inc. | $20 | Food and Beverage | In-kind items and services | OCREVUS Biological, Immunology | 2019 | |
| 2019-07-16 | Genentech USA, Inc. | $2,525 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | OCREVUS Biological, Immunology | 2019 | |
| 2019-07-16 | Genentech USA, Inc. | $23 | Food and Beverage | In-kind items and services | OCREVUS Biological, Immunology | 2019 | |
| 2019-06-26 | Teva Pharmaceuticals USA, Inc. | $1,410 | Consulting Fee | Cash or cash equivalent | AJOVY Drug, Central Nervous System | 2019 | |
| 2019-06-25 | Novartis Pharmaceuticals Corporation | $2,660 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | GILENYA Drug, NEUROSCIENCE | 2019 | |
| 2019-06-25 | Novartis Pharmaceuticals Corporation | $122 | Food and Beverage | In-kind items and services | GILENYA Drug, NEUROSCIENCE | 2019 | |
| 2019-06-08 | Genentech USA, Inc. | $2,450 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | OCREVUS Biological, Immunology | 2019 | |
| 2019-06-08 | Genentech USA, Inc. | $408 | Travel and Lodging | Cash or cash equivalent | OCREVUS Biological, Immunology | 2019 | |
| 2019-06-08 | Genentech USA, Inc. | $324 | Food and Beverage | In-kind items and services | OCREVUS Biological, Immunology | 2019 | |
| 2019-06-08 | Genentech USA, Inc. | $265 | Travel and Lodging | Cash or cash equivalent | OCREVUS Biological, Immunology | 2019 | |
| 2019-05-30 | Novartis Pharmaceuticals Corporation | $80 | Food and Beverage | In-kind items and services | MAYZENT Drug, NEUROSCIENCE | 2019 | |
| 2019-05-29 | Novartis Pharmaceuticals Corporation | $31 | Food and Beverage | In-kind items and services | MAYZENT Drug, NEUROSCIENCE | 2019 | |
| 2019-05-28 | Novartis Pharmaceuticals Corporation | $39 | Food and Beverage | In-kind items and services | MAYZENT Drug, NEUROSCIENCE | 2019 | |
| 2019-05-18 | Novartis Pharmaceuticals Corporation | $1,750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2019 | ||
| 2019-05-18 | Novartis Pharmaceuticals Corporation | $128 | Food and Beverage | In-kind items and services | 2019 | ||
| 2019-05-14 | Genentech USA, Inc. | $2,525 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | OCREVUS Biological, Immunology | 2019 | |
| 2019-05-14 | Genentech USA, Inc. | $29 | Food and Beverage | In-kind items and services | OCREVUS Biological, Immunology | 2019 | |
| 2019-04-24 | Biogen, Inc. | $2,880 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | TECFIDERA Drug, NEUROLOGY | 2019 | |
| 2019-04-24 | Biogen, Inc. | $46 | Food and Beverage | Cash or cash equivalent | TECFIDERA Drug, NEUROLOGY | 2019 | |
| 2019-04-16 | Novartis Pharmaceuticals Corporation | $39 | Food and Beverage | In-kind items and services | 2019 | ||
| 2019-04-12 | Biogen, Inc. | $6,660 | Consulting Fee | Cash or cash equivalent | 2019 | ||
| 2019-03-28 | Biogen, Inc. | $4,680 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | TECFIDERA Drug, NEUROLOGY | 2019 | |
| 2019-03-28 | Biogen, Inc. | $509 | Travel and Lodging | Cash or cash equivalent | TECFIDERA Drug, NEUROLOGY | 2019 | |
| 2019-03-28 | Biogen, Inc. | $419 | Travel and Lodging | Cash or cash equivalent | TECFIDERA Drug, NEUROLOGY | 2019 | |
| 2019-03-28 | Biogen, Inc. | $416 | Travel and Lodging | Cash or cash equivalent | TECFIDERA Drug, NEUROLOGY | 2019 | |
| 2019-03-28 | Biogen, Inc. | $116 | Food and Beverage | Cash or cash equivalent | TECFIDERA Drug, NEUROLOGY | 2019 | |
| 2019-03-24 | Biogen, Inc. | $170 | Travel and Lodging | Cash or cash equivalent | 2019 | ||
| 2019-03-23 | Biogen, Inc. | $80 | Food and Beverage | Cash or cash equivalent | 2019 | ||
| 2019-03-23 | Biogen, Inc. | $69 | Food and Beverage | Cash or cash equivalent | 2019 | ||
| 2019-03-23 | Biogen, Inc. | $38 | Food and Beverage | Cash or cash equivalent | 2019 | ||
| 2019-03-23 | Biogen, Inc. | $36 | Food and Beverage | Cash or cash equivalent | 2019 | ||
| 2019-03-23 | Biogen, Inc. | $12 | Food and Beverage | Cash or cash equivalent | 2019 | ||
| 2019-03-22 | Teva Pharmaceuticals USA, Inc. | $2,115 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | COPAXONE Drug, Central Nervous System | 2019 | |
| 2019-03-22 | Biogen, Inc. | $386 | Travel and Lodging | Cash or cash equivalent | 2019 | ||
| 2019-03-22 | Biogen, Inc. | $169 | Travel and Lodging | Cash or cash equivalent | 2019 | ||
| 2019-03-22 | Biogen, Inc. | $134 | Food and Beverage | Cash or cash equivalent | 2019 | ||
| 2019-03-22 | Biogen, Inc. | $100 | Travel and Lodging | Cash or cash equivalent | 2019 | ||
| 2019-03-20 | Biogen, Inc. | $2,520 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | TECFIDERA Drug, NEUROLOGY | 2019 | |
| 2019-03-20 | Biogen, Inc. | $43 | Food and Beverage | Cash or cash equivalent | TECFIDERA Drug, NEUROLOGY | 2019 | |
| 2019-02-20 | Biogen, Inc. | $2,880 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | TECFIDERA Drug, NEUROLOGY | 2019 | |
| 2019-02-20 | Biogen, Inc. | $25 | Food and Beverage | Cash or cash equivalent | TECFIDERA Drug, NEUROLOGY | 2019 |
Research payments naming this person as principal investigator
| Date | Company | Paid to | Amount | Study | Year |
|---|---|---|---|---|---|
| 2025-10-14 | GENZYME CORPORATION | ALLEGHENY HEALTH NETWORK | $1,000 | Master Protocol of Two Independent, Randomized, Double-blind, Phase 3 Studies Comparing Efficacy and Safety of Frexalima | 2025 |
| 2025-07-28 | GENZYME CORPORATION | ALLEGHENY HEALTH NETWORK | $1,000 | Master Protocol of Two Independent, Randomized, Double-blind, Phase 3 Studies Comparing Efficacy and Safety of Frexalima | 2025 |
| 2025-05-27 | GENZYME CORPORATION | ALLEGHENY HEALTH NETWORK | $14,800 | Master Protocol of Two Independent, Randomized, Double-blind, Phase 3 Studies Comparing Efficacy and Safety of Frexalima | 2025 |
| 2023-11-21 | Genentech, Inc. | ALLEGHENY SINGER RESEARCH INST DBA AHN RESEARCH INSTITUTE | $1,500 | Evaluation of Fenebrutinib in RMS patients II | 2023 |
| 2023-10-05 | Genentech, Inc. | ALLEGHENY SINGER RESEARCH INST DBA AHN RESEARCH INSTITUTE | $1,000 | Evaluation of Fenebrutinib in RMS patients II | 2023 |
| 2023-07-14 | Biogen, Inc. | Allegheny-Singer Research Institute | $1,919 | A Multicenter Global Observational Study to Collect Information on Safety and to Document the Drug Utilization of Tecfid | 2023 |
| 2023-07-10 | Genentech, Inc. | ALLEGHENY SINGER RESEARCH INST DBA AHN RESEARCH INSTITUTE | $1,000 | Evaluation of Fenebrutinib in RMS patients II | 2023 |
| 2023-03-13 | Genentech, Inc. | ALLEGHENY SINGER RESEARCH INST DBA AHN RESEARCH INSTITUTE | $2,000 | Evaluation of Fenebrutinib in RMS patients II | 2023 |
| 2022-08-15 | Biogen, Inc. | Allegheny-Singer Research Institute | $2,842 | Plegridy (peginterferon 1a) Real World Effectiveness and Safety Observational Program | 2022 |
| 2022-07-15 | Genentech, Inc. | ALLEGHENY SINGER RESEARCH INSTITUTE | $1,000 | EVALUATION OF FENEBRUTINIB IN RMS PATIENTS II | 2022 |
| 2021-06-27 | Genentech, Inc. | ALLEGHENY GENERAL HOSPITAL | $18,400 | EVALUATION OF FENEBRUTINIB IN RMS PATIENTS II | 2021 |
| 2021-06-18 | Biogen, Inc. | Allegheny-Singer Research Institute | $2,800 | Dimethyl Fumarate (DMF) Observational Study | 2021 |
| 2021-04-16 | Novartis Pharmaceuticals Corporation | ALLEGHENYSINGER RESEARCH INSTITUTE ASRI RESEARCH CONCENTRATION | $1,285 | A RANDOMIZED DOUBLE BLIND DOUBLE DUMMY PARALLEL GROUP STUDY COMPARING THE EFFICACY AND SAFETY OF OFATUMUMAB ADMINISTERED | 2021 |
| 2021-04-01 | Biogen, Inc. | Allegheny-Singer Research Institute | $519 | Plegridy Observational Program | 2021 |
| 2020-06-11 | Novartis Pharmaceuticals Corporation | ALLEGHENYSINGER RESEARCH INSTITUTE ASRI RESEARCH CONCENTRATION | $8,315 | A RANDOMIZED DOUBLE BLIND DOUBLE DUMMY PARALLEL GROUP STUDY COMPARING THE EFFICACY AND SAFETY OF OFATUMUMAB ADMINISTERED | 2020 |
| 2020-01-28 | Biogen, Inc. | ALLEGHENY SINGER RESEARCH INSTITUTE | $6,300 | Dimethyl Fumarate (DMF) Observational Study | 2020 |
| 2020-01-02 | Biogen, Inc. | ALLEGHENY SINGER RESEARCH INSTITUTE | $3,284 | Plegridy Observational Program | 2020 |
| 2019-09-09 | Genentech, Inc. | ALLEGHENY SINGER RESEARCH INSTITUTE | $1,000 | MNT CHORDS | 2019 |
| 2019-08-26 | Genentech, Inc. | ALLEGHENY SINGER RESEARCH INSTITUTE | $400 | MNT CHORDS | 2019 |
| 2019-08-20 | Biogen, Inc. | Allegheny-Singer Research Institute | $23,255 | Dimethyl Fumarate (DMF) Observational Study | 2019 |
| 2019-08-19 | Genentech, Inc. | ALLEGHENY SINGER RESEARCH INSTITUTE | $18,217 | MNT CHORDS | 2019 |
| 2019-08-19 | Genentech, Inc. | ALLEGHENY SINGER RESEARCH INSTITUTE | $1,500 | MNT CHORDS | 2019 |
| 2019-08-19 | Genentech, Inc. | ALLEGHENY SINGER RESEARCH INSTITUTE | $75 | MNT CHORDS | 2019 |
| 2019-08-19 | Genentech, Inc. | ALLEGHENY SINGER RESEARCH INSTITUTE | $37 | MNT CHORDS | 2019 |
| 2019-08-19 | Genentech, Inc. | ALLEGHENY SINGER RESEARCH INSTITUTE | $37 | MNT CHORDS | 2019 |
| 2019-07-01 | Genentech, Inc. | ALLEGHENY SINGER RESEARCH INSTITUTE | $696 | MNT CHORDS | 2019 |
| 2019-06-10 | Genentech, Inc. | ALLEGHENY SINGER RESEARCH INSTITUTE | $400 | MNT CHORDS | 2019 |
| 2019-05-06 | Genentech, Inc. | ALLEGHENY SINGER RESEARCH INSTITUTE | $4,386 | MNT CHORDS | 2019 |
| 2019-02-11 | Genentech, Inc. | ALLEGHENY SINGER RESEARCH INSTITUTE | $17,546 | MNT CHORDS | 2019 |
| 2019-01-28 | Genentech, Inc. | ALLEGHENY SINGER RESEARCH INSTITUTE | $400 | MNT CHORDS | 2019 |
| 2019-01-22 | Novartis Pharmaceuticals Corporation | ALLEGHENYSINGER RESEARCH INSTITUTE ASRI RESEARCH CONCENTRATION | $6,728 | A RANDOMIZED DOUBLE BLIND DOUBLE DUMMY PARALLEL GROUP STUDY COMPARING THE EFFICACY AND SAFETY OF OFATUMUMAB ADMINISTERED | 2019 |
| 2019-01-16 | Biogen, Inc. | Allegheny-Singer Research Institute | $2,286 | Plegridy Observational Program | 2019 |
| 2019-01-07 | Genentech, Inc. | ALLEGHENY SINGER RESEARCH INSTITUTE | $347 | MNT CHORDS | 2019 |
| 2019-01-02 | Biogen, Inc. | Allegheny-Singer Research Institute | $8,122 | Effectiveness of DMF and Its Impact on PROs in Suboptimal GA Responders With RMS | 2019 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Clairton, PA, county Allegheny County, PA, state Pennsylvania; placed by its city name.
| Measure | Place (city or town) Clairton, PA | County Allegheny County, PA | State Pennsylvania |
|---|---|---|---|
| Population B01003 | 6,044 | 1,238,177 | 13,018,639 |
| Population, 2020 census P1 | 6,181 | 1,250,578 | 13,002,700 |
| Median age B01002 | 41.5 | 40.6 | 40.9 |
| Under 18 B01001 | 24.7% | 18.6% | 20.4% |
| 65 and over B01001 | 24.4% | 20.2% | 19.5% |
| Households B11001 | 2,715 | 545,802 | 5,274,853 |
| Foreign born B05002 | 4.1% | 6.6% | 7.7% |
| Median household income B19013 | $36,538 | $78,548 | $77,971 |
| Median family income B19113 | $46,047 | $109,346 | $100,262 |
| Per capita income B19301 | $26,112 | $49,588 | $44,355 |
| Poverty rate B17001 | 33.0% | 11.5% | 11.7% |
| Unemployment rate B23025 | 8.2% | 5.0% | 5.3% |
| Civilian labor force B23025 | 2,493 | 669,885 | 6,684,175 |
| Mean commute (minutes) B08013 | 30.6 | 25.2 | 26.3 |
| Bachelor's degree or higher B15003 | 21.2% | 45.8% | 35.2% |
| Housing units B25001 | 3,592 | 606,827 | 5,806,452 |
| Owner-occupied B25003 | 61.1% | 65.2% | 69.3% |
| Renters B25003 | 38.9% | 34.8% | 30.7% |
| Median home value B25077 | $66,500 | $227,600 | $254,500 |
| Median gross rent B25064 | $1,009 | $1,153 | $1,209 |
| White, not Hispanic B03002 | 45.3% | 75.5% | 73.0% |
| Black B03002 | 43.9% | 12.4% | 10.3% |
| Hispanic or Latino B03002 | 4.0% | 3.0% | 8.7% |
| Asian B03002 | 0.0% | 4.3% | 3.8% |
| American Indian and Alaska Native B03002 | 0.0% | 0.1% | 0.1% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Clairton, PA.
Comments